CHRNA6 Antibody - N-terminal region
Rabbit Polyclonal Antibody
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| WB |
---|---|
Primary Accession | Q15825 |
Other Accession | NM_004198, NP_004189 |
Reactivity | Human, Mouse, Rat, Dog |
Predicted | Human, Mouse, Rat, Chicken, Dog |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 56898 Da |
Gene ID | 8973 |
---|---|
Alias Symbol | CHNRA6 |
Other Names | Neuronal acetylcholine receptor subunit alpha-6, CHRNA6 |
Format | Lyophilized |
Reconstitution & Storage | Add 50 ul of distilled water. Final anti-CHRNA6 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles. |
Precautions | CHRNA6 Antibody - N-terminal region is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | CHRNA6 (HGNC:15963) |
---|---|
Function | Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, cation permeability, and binding to allosteric modulators (Probable). CHRNA6 forms pentameric channels with CHRNB2, CHRNB3 and CHRNA4 that exhibit high sensitivity to ACh and nicotine and are predominantly expressed in only a few brain areas, including dopaminergic neurons, norepirephrine neurons and cells of the visual system (PubMed:16835356). nAChrs containing CHRNA6 subunits mediate endogenous cholinergic modulation of dopamine and gamma-aminobutyric acid (GABA) release in response to nicotine at nerve terminals. |
Cellular Location | Synaptic cell membrane {ECO:0000250|UniProtKB:Q9R0W9}; Multi-pass membrane protein |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
REFERENCES
Elliott K.J.,et al.J. Mol. Neurosci. 7:217-228(1996).
Groot Kormelink P.J.,et al.Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
Ebihara M.,et al.Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Nusbaum C.,et al.Nature 439:331-335(2006).

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.